Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Nippon Shinyaku
Nippon Shinyaku
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Viltepso
Viltolarsen
2020-08-12
2031
Duchenne muscular dystrophy
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Viltolarsen
duchenne muscular dystrophy
,
muscular dystrophies
Aglatimagene besadenovec
breast neoplasms
,
ovarian neoplasms
,
neoplasms
,
gastrointestinal neoplasms
,
lung neoplasms
,
digestive system neoplasms
,
prostatic neoplasms
Alfacalcidol
dermatomyositis
,
ulcerative colitis
,
colitis
,
ulcer
,
hyperparathyroidism
,
secondary hyperparathyroidism
,
neoplasm metastasis
,
chronic renal insufficiency
,
left ventricular hypertrophy
,
kidney diseases
,
cardiomegaly
,
hypertrophy
ILGINATINIB
essential thrombocythemia
,
polycythemia vera
,
primary myelofibrosis
,
thrombocytosis
,
polycythemia
Microcrystalline cellulose
follicular lymphoma
,
large b-cell lymphoma diffuse
,
leukemia
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
lymphoma
,
non-hodgkin lymphoma
,
t-cell lymphoma
,
t-cell lymphoma peripheral
,
myelodysplastic syndromes
,
myeloproliferative disorders
,
multiple myeloma
,
hematologic diseases
,
anemia
,
hodgkin disease
,
aplastic anemia
,
preleukemia
,
myeloid leukemia chronic-phase
,
b-cell leukemia
,
infections
,
communicable diseases
,
infectious skin diseases
,
skin diseases
,
bacterial infections
,
soft tissue infections
,
recurrence
,
glioblastoma
,
respiratory tract infections
,
sinusitis
,
type 2 diabetes mellitus
,
chronic renal insufficiency
,
renal insufficiency
,
metabolic diseases
,
metabolic bone diseases
,
hyperphosphatemia
,
bone diseases
,
bacterial skin diseases
Potassium magnesium citrate (4:1:2)
follicular lymphoma
,
large b-cell lymphoma diffuse
,
leukemia
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
lymphoma
,
non-hodgkin lymphoma
,
t-cell lymphoma
,
t-cell lymphoma peripheral
,
myelodysplastic syndromes
,
myeloproliferative disorders
,
multiple myeloma
,
hematologic diseases
,
anemia
,
hodgkin disease
,
aplastic anemia
,
preleukemia
,
myeloid leukemia chronic-phase
,
b-cell leukemia
,
infections
,
communicable diseases
,
infectious skin diseases
,
skin diseases
,
bacterial infections
,
soft tissue infections
,
recurrence
,
glioblastoma
,
type 2 diabetes mellitus
,
chronic renal insufficiency
,
renal insufficiency
,
metabolic diseases
,
metabolic bone diseases
,
hyperphosphatemia
,
bone diseases
,
bacterial skin diseases
Potassium nitrate
leukemia
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use